association statin-associated myopathy skeletal muscle damage abstract background patients taking statins complain muscle pain weakness extent muscle pain reflects muscle injury unknown methods obtained biopsy samples vastus lateralis muscle num patients num patients clinically diagnosed statin-associated myopathy num taking statin num discontinued statin therapy biopsy minimal duration discontinuation num weeks included num patients taking statins myopathy num patients statins myopathy classified muscles injured num muscle fibres biopsy sample showed damage reverse transcriptase polymerase chain reaction evaluated expression levels candidate genes potentially related myocyte injury results muscle injury observed num num patients myopathy num patient myopathy num patient structural injury circulating level creatine phosphokinase elevated num u/l num upper limit normal expression ryanodine receptor num significantly upregulated patients biopsy evidence structural damage num standard error num interpretation persistent myopathy patients taking statins reflects structural muscle damage lack elevated levels circulating creatine phosphokinase rule structural muscle injury upregulation expression ryanodine receptor num suggestive intracellular calcium leak 
